Bronchiectasis Medical Slides
Generate publication-quality bronchiectasis lecture slides in 30 seconds. AI-powered content structured for clinical education.
Generate Bronchiectasis DeckWhy teach Bronchiectasis?
Bronchiectasis prevalence has increased by 40% over the past decade, affecting approximately 350-566 per 100,000 adults. Post-infectious causes remain most common globally, though idiopathic bronchiectasis accounts for 30-50% of cases in developed countries. The 2017 ERS guidelines provide the framework for etiological workup, and the Bronchiectasis Severity Index (BSI) guides risk stratification and management intensity.
What AI generates for Bronchiectasis
Enter “Bronchiectasis” and SlideCraft generates a complete lecture deck with slides like these.
Veja em ação
Digite qualquer tema médico e veja a IA gerar um slide de apresentação em segundos. Sem necessidade de cadastro.
3 previews gratuitos por hora · Sem necessidade de conta
Digite um tema e clique em Gerar para ver seu slide com IA
Bronchiectasis Presentation FAQ
What etiological workup should be presented in bronchiectasis teaching?
Present the ERS 2017 minimum workup: immunoglobulins (IgG, IgA, IgM — immunodeficiency in 2-8%), specific antibody responses, ABPA screen (total IgE, Aspergillus-specific IgE/IgG — ABPA in 1-10%), sputum culture (including mycobacteria), and consider: CF testing (sweat chloride + CFTR genetics, especially if age <40), alpha-1 antitrypsin level, ciliary function testing, autoimmune panel. Up to 30-50% remain idiopathic despite comprehensive evaluation.
How should long-term macrolide evidence be presented?
Present the three landmark trials: EMBRACE (azithromycin 500 mg 3x/week reduced exacerbations, NZ), BAT (azithromycin 250 mg daily reduced exacerbations by 70%, Netherlands), BLESS (erythromycin 400 mg twice daily reduced exacerbations, Australia). Common findings: approximately 50% reduction in exacerbation frequency. Key considerations: screen for NTM before starting (risk of macrolide resistance), ECG for QTc prolongation, hearing assessment, liver function monitoring. ERS recommends for ≥3 exacerbations/year.
What Pseudomonas management strategy should be covered?
Present the significance: Pseudomonas colonization is associated with 3-fold increased mortality and accelerated lung function decline. Eradication protocol at first isolation: IV anti-pseudomonal antibiotics or inhaled colistin/tobramycin for 2-4 weeks. Chronic Pseudomonas: long-term inhaled antibiotics (nebulized colistin, tobramycin, or aztreonam in 28-day on/off cycles). Reference RESPIRE 1 and 2 trials for inhaled ciprofloxacin dry powder. BSI scoring guides treatment intensity.
Preços simples, sem surpresas
Comece grátis hoje. Assine quando seu departamento precisar de mais.
Gratuito
Experimente o SlideCraft sem compromisso
- 2 apresentações por mês
- Slides com IA + notas do apresentador
- Visualizar e apresentar (sem exportar)
- Armazenamento na nuvem por 7 dias
- Slide Checker & Outline Generator
Pro
Para clínicos que dão aula toda semana
- 10 apresentações/mês + $2.50/extra
- Modo Crítico com IA (análise 5 eixos)
- Documento para apresentação (PDF)
- Exportar PDF, PPTX, SCORM e imagem
- Armazenamento permanente na nuvem
Expert
Para médicos acadêmicos que publicam e apresentam
- 25 apresentações/mês + $2.00/extra
- Verificação de fontes PubMed
- Pipeline artigo-para-apresentação
- Citações automáticas (Vancouver)
- Tudo do plano Pro